60 Degrees Pharmaceuticals, Inc. Common Stock

NASDAQ:SXTP USA Biotechnology
Market Cap
$2.90 Million
Market Cap Rank
#34101 Global
#11119 in USA
Share Price
$2.25
Change (1 day)
+0.45%
52-Week Range
$0.47 - $5.20
All Time High
$56.16
About

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indicatio… Read more

60 Degrees Pharmaceuticals, Inc. Common Stock - Asset Resilience Ratio

Latest as of September 2025: 0.00%

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$0.00
Cash + Short-term Investments
Total Assets
$6.69 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how 60 Degrees Pharmaceuticals, Inc. Common Stock's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down 60 Degrees Pharmaceuticals, Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: 60 Degrees Pharmaceuticals, Inc. Common Stock maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

60 Degrees Pharmaceuticals, Inc. Common Stock Industry Peers by Asset Resilience Ratio

Compare 60 Degrees Pharmaceuticals, Inc. Common Stock's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for 60 Degrees Pharmaceuticals, Inc. Common Stock (2024–2024)

The table below shows the annual Asset Resilience Ratio data for 60 Degrees Pharmaceuticals, Inc. Common Stock.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 30.01% $1.73 Million $5.76 Million --
pp = percentage points